Status:
COMPLETED
Visual Outcome After Vitrectomy With Subretinal tPA Injection
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Age-Related Macular Degeneration
Eligibility:
All Genders
18+ years
Brief Summary
evaluate the safety of Eva surgical system
Detailed Description
The purpose of this retrospective study is to evaluate the safety and clinical results using this surgical technique when performed using the EVA surgical system and associated instrumentation and dis...
Eligibility Criteria
Inclusion
- patients with VTX subretinal tPA ( + phaco)
- patients with submacular bleeding
Exclusion
- none
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 16 2021
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT05196139
Start Date
April 1 2021
End Date
August 16 2021
Last Update
January 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Belgium, 3000